Consequently, GIP receptor antagonism was proposed as a potential strategy for treating obesity-related diabetes (73)
In our latest article, Professor Tim Sandle, Ph.D., CBiol, FIScT explores what these updates mean in practice, including the need to reconfirm method suitability, strengthen media qualification and review existing procedures
And some that look promising today will fail for reasons that have nothing to do with efficacy
At the center of the platform is Twins AI-powered Digital Twin technology, which continuously analyzes biometric and behavioral dataincluding glucose levels, weight, activity and lab resultsto provide personalized recommendations and help clinicians adjust care in real time
Reid IR, Baldock PA, Cornish J
The research highlights a pivot toward healthier lifestyles among GLP-1 users, driven by a 41-point increase in weight management being cited as their primary health goal since 2021